Zoey the cockapoo greeted life with tail-wagging joy. A mass of tawny curls, she loved everyone, and they loved her back.
Efficient delivery of synthetic mRNA to the retina remains one of the key hurdles in developing mRNA-based treatments for vision loss.
Retinal blindness caused by the death of photoreceptors, the light-sensing cells within the retina, affects millions of people worldwide. Novel gene and cell therapies to prevent or rescue vision loss…
Researchers identify metabolic stress as an obstacle to photoreceptor transplantation highlighting a critical window for therapeutic intervention.
A collaborative team of researchers led by vision scientists at the School of Veterinary Medicine have developed novel promoters that drive strong and specific gene expression in rod and cone…
Eight faculty from four University of Pennsylvania schools have been elected 2022 American Association for the Advancement of Science (AAAS) Fellows. They are among more than 500 researchers honored for…
Andrew M. Hoffman, DVM, DVSc, DACVIM, Gilbert S. Kahn Dean of the School of Veterinary Medicine at the University of Pennsylvania (Penn Vet) has named William Beltran, DVM, MSc, PhD,…
Awards represent the Institute for Infectious and Zoonotic Diseases’ long-term vision of supporting research that advances understanding of infectious diseases.
Researchers in the School of Veterinary Medicine and colleagues have developed a gene therapy that restores dim-light vision in dogs with a congenital form of night blindness, offering hope for…
Dr. William A. Beltran and Dr. David M. Gamm have been awarded CAD$725,000 from Fighting Blindness Canada’s Restore Vision 20/20 program to continue their ground-breaking research into cell replacement therapy…
